Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0001209191-19-052270

Options or other derivatives

  • Director acquired 12,509 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Ros Matthew Director 2019-10-01 Grant or award · Stock Option (Right to Buy) +12,509 $0.88 $11,000 12,509 D
Loading xslF345X03/doc4.xml…